Clinical Trials Logo

Aceruloplasminemia clinical trials

View clinical trials related to Aceruloplasminemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT04184453 Recruiting - Aceruloplasminemia Clinical Trials

Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients

Start date: December 23, 2019
Phase: Early Phase 1
Study type: Interventional

Aceruloplasminemia is an autosomal recessive disorder characterized by iron deposition in the brain and visceral organs. Deferiprone was used to treat aceruloplasminemia in previous study. In this study, we will assess the clinical curative effect evaluation of oral deferiprone in Chinese aceruloplasminemia patients.